UK Chronic Inflammatory Demyelinating Polyneuritis Market Analysis


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Europe
  • Country: UK
  • Report ID : 2571

  • Format: PPT, PDF

UK Chronic Inflammatory Demyelinating Polyneuritis Therapeutics Market: Segmented by Treatment, Diagnosis, Route of Administration, and End-Users – Size, Share, Impact, Growth, Trends, and Forecasts (2020 – 2028)

Published Date: June 2021

SKU: 2571 Categories: ,

Report Overview

The UK Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics market size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Chronic Inflammatory Demyelinating Polyneuritis (CIDP) is a rare autoimmune disorder wherein the body’s immune system attacks the myelin causing various symptoms such as numbness, weakness, and a lack of certain reflexes.

CIDP is a rare disorder that can affect any age group and the onset of order may begin during the decade of life. It has been estimated that over 10 million people in the UK (adults and children) suffer from a neurological disorder that has a significant impact on their lives. CIDP affects males twice as often as females and the average age of onset is 50. The incidence (1.6/100,000/year) and prevalence (8.9/100,000) of CIDP have been shown in the UK.

Market Growth Drivers

The prevalence of CIDP has increased dramatically, paving the way for the growth of the UK market for CIDP. The increasing incidence of CIDP is a major concern in the medical sector, hence the major market growth driver as well. Therefore, the high unmet need for advanced treatment options for the disease is likely to bring to view new opportunities for market players over the forecast period.

Several public and private organizations launched initiatives for R&D activities that produced positive results in the market of ​​CIDP. Remarkable results have been achieved through rigorous research and development efforts and clinical trials. Several new drugs are introduced following recent FDA approvals, which also spur the growth of the CIDP market. Other factors supporting the market growth comprise surging awareness of the disease and government endeavors on the same.

Market Restraints

On the downside, the high cost of intravenous immunoglobulin (IVIG) treatment and the side effects accompanied with its administration such as hypotension, nausea, lower back pain, flushing, chills, wheezing, etc. remain a hindrance to the growth of the market.


1. UK CIDP Therapeutics Market Overview………………………………………
A. Market Size
2. Market Growth Drivers and Restraints…………………………………….
Market Growth Drivers
A. Rising Prevalence of Chronic Inflammatory Demyelinating Polyneuritis
B. Rigorous Research and Development Efforts and clinical Trials
C. Increasing Awareness about CIDP disease
Market Restraints
A. High cost of the Intravenous Immunoglobulin (IVIG) Treatment
B. Adverse Effects Associated with the Treatment
3. Epidemiology of Chronic Inflammatory Demyelinating Polyneuritis………
A. Criteria to Determine Prevalence and Incidence of CIDP
B. European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS) Criteria
C. American Academy of Neurology (AAN) Criteria
4. CIDP Therapeutics Market Segmentation…………………………………………
A. By Treatment
I. Intravenous Immunoglobulin (IVIG)
II. Corticosteroids
III. Plasmapheresis (Plasma Exchange)
IV. Physiotherapy
V. Others
B. By Diagnosis
I. Electrodiagnostic Testing
II. Nerve Conduction
IV. Spinal Fluid Analysis
V. Others
C. By Route of Administration
I. Intravenous (IV)
II. Oral
III. Others
D. By End Users
I. Hospitals
II. Speciality Neurological Clinics
III. Research and Academic Laboratories
IV. Others
5. CIDP Major Drugs Market Share………………………………
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Grifols Company overview, Product & Services, Strategies & Financials
B. Kedrion Company overview, Product & Services, Strategies & Financials
C. CSL Behring Company, Product & Services, Strategies & Financials
D. Shire Company overview, Product & Services, Strategies & Financials
E. Octapharma Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………
A. New Trends and Development of CIDP Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment:

The treatment segment which holds the most significant share of the CIDP treatment market is segmented into

  • Intravenous Immunoglobulin (IVIG)
  • Corticosteroids
  • Plasmapheresis (Plasma Exchange)
  • Physiotherapy
  • Others

By Diagnosis:

Based on the diagnosis, the CIDP treatment market is bifurcated into

  • Electrodiagnostic Testing
  • Nerve Conduction
  • EMG
  • Spinal Fluid Analysis
  • Others

Among the various sub-segments, the IVIG sub-segment has achieved a leadership status due to the preference for IVIG as the first line of treatment for CIDP, thus in turn, the treatment segment fosters the CIDP market during the forecast period.

By Route of Administration:

The route of administration of CIDP medication has been segmented into

  • Oral
  • Intravenous
  • Others

Due to the high preference for IVIG treatment which enters the bloodstream directly to react faster, the intravenous segment is growing at the highest CAGR during the forecast period. The intravenous segment also accounts maximum of the UK market share, followed by oral and others.

By End Users:

The end-users of the CIDP market have been classified into

  • Hospitals
  • Specialty neurological clinics
  • Research & academic laboratories
  • Others

Hospitals have gained a maximum share of the UK market due to their widespread presence and the preference for hospitals among patients. However, the specialty neurological clinics segment is also growing at the most rapid CAGR during the forecast period.

Top Major Players

Numerous players are operating in the CIDP market. Some of the big players have captured a significant share in the UK market taking advantage of their strong position and presence. The top major key players operating in the UK CIDP market are Grifols, CSL Behring, Shire, Octapharma, and Kedrion Biopharma. Grifols held the first position in the UK CIDP market with a huge market share. It is one of the largest and fastest-growing market players in plasma-derived medicines. The polyvalent immunoglobulins of the Kedrion Biopharma were approved by the authorities to include in the CIDP treatment regimens.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements